Jeena Sikho Lifecare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2025.1. Approval of ESOP 20252. Appointment of Mr. Sahil Jain as the Chief Operating Officer (COO)3. Appointment of M/s Ankur Singh & Associates as the Secretarial Auditor4. Annual Report (2024-25)5. Notice of the 8th Annual General Meeting (AGM)6. Fixation of Dividend Record Date7. Re-designation of Ms. Shreya Grover (DIN: 09199495) as Whole-Time Director and a Key Managerial Personnel of the Company from the position of Non-Executive Director8. Appointment of Scrutinizer for the proposed 8th Annual General Meeting of the Company9. Book Closure
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Jeena Sikho Lifecare approved several key items in its meeting on August 27, 2025. A new Employee Stock Option Scheme (ESOP 2025) was approved, offering up to 2,50,000 stock options at an exercise price of Rs. 2 per share, subject to shareholder approval. Mr. Sahil Jain, an internal candidate with 8 years at the company, was appointed as Chief Operating Officer. Ms. Shreya Grover, daughter of Managing Director Mr. Manish Grover, was re-designated from Non-Executive Director to Whole-Time Director and Key Managerial Personnel for a 5-year term. M/s Ankur Singh & Associates was appointed as Secretarial Auditor for FY 2025-26 to FY 2029-30. The company confirmed a final dividend of Rs. 1.10 per equity share (face value Rs. 2) for FY25, with the record date set as September 22, 2025.
The appointment of an internal COO signals operational continuity. The elevation of the promoter's daughter to a Whole-Time Director role reinforces family leadership at the executive level. The Rs. 1.10 dividend offers modest yield, and the ESOP at a very low exercise price of Rs. 2 could lead to future dilution if exercised.